Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) EBT Margin Growth (1y) (2013 - 2026)

Analysis

Iqvia Holdings (IQV) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -115.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 80.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -450.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -162.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 5,201.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -14,710.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 51.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.77 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -751,066.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -115.00
Mar 31, 2026 -53.00
Dec 31, 2025 -144.00
Sep 30, 2025 99.00
Jun 30, 2025 -339.00
Mar 31, 2025 -66.00
Dec 31, 2024 410.00
Sep 30, 2024 -38.00
Jun 30, 2024 137.00
Mar 31, 2024 -81.00
Dec 31, 2023 229.00
Sep 30, 2023 -77.00
Jun 30, 2023 80.00
Mar 31, 2023 -130.00
Dec 31, 2022 -299.00
Sep 30, 2022 206.00
Jun 30, 2022 281.00
Mar 31, 2022 367.00
Dec 31, 2021 446.00
Sep 30, 2021 439.00